✦ LIBER ✦

Bacillus calmete-guérin plus interferon-α2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity

✍ Scribed by John S. Lam; Mitchell C. Benson; Michael A. O’Donnell; Alexandra Sawczuk; Anna Gavazzi; Michael H. Wechsler; Ihor S. Sawczuk

Book ID: 117724271
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 80 KB
Volume: 21
Category: Article
ISSN: 1078-1439
DOI: 10.1016/s1078-1439(03)00012-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Intravesical Baci

Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Plus Interferon α-2b Therapy for Nonmuscle Invasive Bladder Cancer in Patients With Prosthetic Devices

✍ Rosevear, Henry M.; Lightfoot, Andrew J.; Nepple, Kenneth G.; O'Donnell, Michael 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 398 KB

SALVAGE INTRAVESICAL THERAPY WITH INTERF

SALVAGE INTRAVESICAL THERAPY WITH INTERFERON-α2B PLUS LOW DOSE BACILLUS CALMETTE-GUERIN IS EFFECTIVE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER IN WHOM BACILLUS CALMETTE-GUERIN ALONE PREVIOUSLY FAILED

✍ O’DONNELL, MICHAEL A.; KROHN, JANICE; DeWOLF, WILLIAM C. 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 83 KB

491 Evaluation of urine interleukin-2 (I

491 Evaluation of urine interleukin-2 (IL2), IL6 and IL10 levels during intravesical therapy with interferon α-2B (IFNα-2B) alone and IFINα-2B combined with low dose bacillus Calmette-Guérin (BCG) in superficial bladder cancer

✍ L. Özdal; T. Özdemir; K. Yakupoǧlu; S. Bulut; A. Memiş; O. Sariyüce 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 207 KB